Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas

Hormone and Metabolic Research

Volumn 38, Issue 2, 2006, Pages 112-118

  Pavel, M E ^a,c   Hoppe, S ^a   Papadopoulos, T ^a   Linder, V ^a   Mohr, B ^a   Hahn, E G ^a   Lohmann, T ^a   Schuppan, D ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Immunohistochemistry; Neuroendocrine tumor; Prognostic marker; Radioimmunoassay

Indexed keywords

ADRENOMEDULLIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BRONCHUS CANCER; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; VASODILATATION;

ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL NEOPLASMS; CARCINOMA, NEUROENDOCRINE; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PEPTIDES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645722179     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925129     Document Type: Article

References (22)

1. Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumors. In: World Health Organization, 2nd edn. Heidelberg: 2000
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959
3. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560
4. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Abe K, Miura Y, Hayashi Y, Sasano H. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metabol 1995; 80: 1750-1752
5. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 1995; 136: 4099-4105
6. Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997; 138: 2615-2620
7. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 1997; 105: 156-162
8. Zudaire E, Martínez A, Cuttitta F. Adrenomedullin and cancer. Regulatory Peptides 2003; 112: 175-183
9. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996; 69: 135-174
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364
11. Nikitenko LL, MacKenzie IZ, Rees MC, Bicknell R. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod 2000; 6: 811-819
12. Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, Bicknell R, Rees MC. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 2000; 6: 2808-2814
13. Klöppel G, Peren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system. WHO system. Ann New York Acad Sci 2004; 1014: 13-27
14. Martinez A, Weaver C, Lopez J, Bhathena SJ, Elsasser TH, Miller MJ, Moody TW, Unsworth EJ, Cuttitta F. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 1996; 137: 2626-2632
15. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees MC. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998; 16: 409-415
16. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson WG, Kleinman HK, Cuttitta F. The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 2002; 94: 1226-1237
17. Rees M, Hague S, Oehler MK, Bicknell R. Regulation of endometrial angiogenesis. Climacteric 1999; 2: 52-58
18. Ouafik S, Sauze F, Boudouresque O, Chinot C, Delfino F, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brunner N, Martin PM. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002; 160: 1279-1292
19. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res 2001; 61: 1196-1206
20. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996; 271: 22345-22351
21. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci (Colch) 1997; 92: 59-62
22. Kuwasako K, Kida O, Kitamura K, Kato J, Eto T. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury. Int Angiol 1997; 16: 272-279